A federal judge has dismissed AbbVie’s constitutional challenge to Tennessee’s Hospital Protection Act, siding with the state’s argument that the law does not conflict with federal drug pricing regulations under the 340B program. AbbVie filed the lawsuit May 6, 2025,…
Pharmacy
St. Jude Children’s Research Hospital in Memphis, Tenn., is leading two clinical trials aimed at expanding HIV treatment and prevention options for the youngest pediatric populations. The hospital was the first site globally to enroll patients in both IMPAACT 2036…
Researchers at the University of Chicago Medicine have developed a lipid nanoparticle system capable of delivering mRNA to insulin-producing beta cells, delaying progression of Type 1 diabetes. In proof-of-concept experiments, the team used nanoparticles made of four lipids to deliver…
Bluesight, a hospital software provider, has partnered with GraphiteRx to integrate marketplace data, including the catalog of Mark Cuban Cost Plus Drugs, into its platforms for drug price checking, purchasing and shortage management. The integration will enable hospital pharmacy teams…
The University of Mississippi School of Pharmacy in Oxford has launched a community pharmacy-based maternal health pilot aimed at expanding prenatal services in underserved areas. The Medications Optimizing Maternal Safety program, or MOMS, operates through the Community Pharmacy Enhanced Services…
Advertisement
Walgreens has introduced a hybrid role that allows pharmacists to split time between in-store community pharmacy work and centralized clinical services. The position enables pharmacists to review prescriptions, provide clinical support and consult with patients and providers from a centralized…
Minnesota state-covered entities generated at least $1.34 billion in net 340B revenue in calendar year 2024 — more than double the $630 million reported in 2023. A Feb. 27 report to the Legislature from the Minnesota Department of Health said…
CarepathRx has joined Evernorth Health Services, a division of the Cigna Group. According to a statement to Becker’s from Evernorth, the acquisition was completed in 2025 as part of the company’s strategy to expand support for patients with specialty conditions…
The FDA has lifted a clinical hold on Intellia Therapeutics’ phase 3 Magnitude trial of nexiguran ziclumeran, or nex-z. The trial was paused Oct. 29 after a patient developed grade 4 liver transaminase elevations and elevated bilirubin following a Sept.…
Over the next three to five years, the chief pharmacy officer role is expected to expand well beyond operational oversight. Dispensing excellence and medication safety will remain foundational. But what will distinguish successful leaders in 2026 and beyond is enterprise-level…